Cyclic Cushing's syndrome: a clinical challenge

被引:104
作者
Meinardi, J. R.
Wolffenbuttel, B. H. R.
Dullaart, R. P. F.
机构
[1] Canisius Wilhelmina Ziekenhuis, Dept Internal Med, NL-6500 GS Nijmegen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 RB Groningen, Netherlands
关键词
D O I
10.1530/EJE-07-0262
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cyclic Cushing's syndrome (CS) is a rare disorder, characterized by repeated episodes of cortisol excess interspersed by periods of normal cortisol secretion. The so-called cycles of hypercortisolism can occur regularly or irregularly with intercyclic phases ranging from days to years. To formally diagnose cyclic CS, three peaks and two troughs of cortisol production should be demonstrated. Our review of 65 reported cases demonstrates that cyclic CS originates in 54%, of cases from a pituitary corticotroph adenoma, in 26% from an ectopic ACTH-producing tumour and in about 11%, from an adrenal tumour, the remainder being unclassified. The pathophysiology of cyclic CS is largely unknown. The majority of patients with cyclic CS have clinical signs of CS, which can be either fluctuating or permanent. In a minority of patients, clinical signs of CS Eire absent. The fluctuating clinical picture and discrepant biochemical findings make cyclic CS extremely hard to diagnose. Clinicians should therefore be aware of this clinical entity and actively search for it in all patients with suspected CS but normal biochemistry or vice versa. Frequent measurements of urinary cortisol or salivary cortisol levels are a reliable and convenient screening tool for suspected cyclic CS. Cortisol stimulation or suppression tests may give spurious results owing to spontaneous falls or rises in serum cortisol at the time of testing. When cyclic CS is biochemically confirmed, further imaging and laboratory studies are guided by the presence or absence of ACTH dependency. In cases of suspected ectopic ACTH production, specific biochemical testing for carcinoids or neuroendocrine tumours is required, including measurements of serotonin in platelets and/or urine. chromogranin A and calcitonin.
引用
收藏
页码:245 / 254
页数:10
相关论文
共 111 条
[31]  
HANNAH J, 1988, CANCER, V61, P2136, DOI 10.1002/1097-0142(19880515)61:10<2136::AID-CNCR2820611034>3.0.CO
[32]  
2-P
[33]   Computed tomography appearance of the thymus and anterior mediastinum in active Cushing's syndrome [J].
Hanson, JA ;
Sohaib, SA ;
Newell-Price, J ;
Islam, N ;
Monson, JP ;
Trainer, PJ ;
Grossman, A ;
Besser, GM ;
Reznek, RH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) :602-605
[34]   Pituitary adenoma showing intermittent secretion of high molecular weight adrenocorticotropin without evidence of Cushing's disease [J].
Hashimoto, K ;
Kaneda, T ;
Nagano, I ;
Asaba, K ;
Takeda, K ;
Takao, T .
HORMONE RESEARCH, 1999, 52 (01) :39-44
[35]   CORTISOL IS SECRETED EPISODICALLY IN CUSHINGS SYNDROME [J].
HELLMAN, L ;
WEITZMAN, ED ;
ROFFWARG, H ;
FUKUSHIMA, DK ;
YOSHIDA, K ;
GALLAGHE.TF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1970, 30 (05) :686-+
[36]   UNPREDICTABLE HYPERSECRETION OF CORTISOL IN CUSHINGS-DISEASE - DETECTION BY DAILY SALIVARY CORTISOL MEASUREMENTS [J].
HERMUS, AR ;
PIETERS, GF ;
BORM, GF ;
VERHOFSTAD, AA ;
SMALS, AG ;
BENRAAD, TJ ;
KLOPPENBORG, PW .
ACTA ENDOCRINOLOGICA, 1993, 128 (05) :428-432
[37]   EFFECT OF HYPOTHALAMIC EXTRACT AND OTHER FACTORS ON RELEASE OF ADRENOCORTICOTROPIN FROM AND ADENOSINE-3',5'-MONOPHOSPHATE LEVELS IN DISPERSED NON-PITUITARY TUMOR-CELLS [J].
HIRATA, Y ;
YOSHIMI, H ;
MATSUKURA, S ;
IMURA, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1979, 49 (03) :317-321
[38]  
HIRATA Y, 1976, CANCER-AM CANCER SOC, V37, P377, DOI 10.1002/1097-0142(197601)37:1<377::AID-CNCR2820370148>3.0.CO
[39]  
2-L
[40]  
HSU TH, 1981, JOHNS HOPKINS MED J, V149, P77